Complex antibody profiling to predict clinical outcome in childhood ADS.
From the Department of Neurology (B.H.), Technische Universität München; Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany; and Department of Neurology (P.A.C.), Johns Hopkins University, School of Medicine, Baltimore, MD. hemmer@lrz.tu-muenchen.de.
Bernhard
B
Hemmer
From the Department of Neurology (B.H.), Technische Universität München; Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany; and Department of Neurology (P.A.C.), Johns Hopkins University, School of Medicine, Baltimore, MD.
Peter A
PA
Calabresi
D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D002493:Central Nervous System Diseases / Q000276:immunology*; D003711:Demyelinating Diseases / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology*
D001323:Autoantibodies; D001324:Autoantigens; D000939:Epitopes